中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.中文简介：（来自Google、百度翻译）使用免疫细胞化学，分子和超微结构技术加强现代诊断病理学证据基础的原始研究手稿将受到欢迎。此外，还将考虑有关诊断标准的严格评估的论文，以及具有坚实证据基础的宽幅表和指南。还将考虑与人类病理学理解有关的其他领域的工作报告，以及有关在病理学中应用新方法和新技术的手稿。不鼓励提交纯实验文章，但欢迎适用于诊断病理学的实验工作手稿。生物标志物研究受到欢迎，但需要遵守严格的规则 (例如备注)，包括足够的样本量和相关的标志物选择。通常不考虑对有限患者系列进行单标记研究，而无需验证应用。仅当病例报告提供大量新信息并对了解疾病或诊断实践产生影响时，才会考虑病例报告。
